Top Stock Losers Today — Aug 6, 2026: Thursday delivered a session that illustrated — with brutal clarity — the three most common ways a stock gets destroyed in August 2026’s unforgiving market: a massively dilutive equity offering below market price, an earnings miss combined with a guidance cut, and a lockup expiration that floods the market with new supply. All three scenarios played out on August 6 — often in the same morning.

Here is the complete loser breakdown.

The Thursday Market Backdrop

The day’s defining paradox: memory stocks that beat Q4 estimates are falling because their Q1 guidance disappointed. The bar in this market isn’t “deliver good results” — it’s “deliver exceptional results AND raise future expectations.”

#1 — YXT (YXT.COM Group Holding Limited) | -65% to $8.18 — The Offering That Destroyed $4 Billion in Market Cap

Benzinga confirmed price: $8.18 (-65%) | High earlier this week: $48+ after 801% surge Wednesday

This is one of the most violent single-session reversals of 2026 — and its mechanics are entirely self-inflicted.

What Happened:

YXT.COM priced a $1.05 million registered direct offering at $7.00 per American Depositary Share (ADS) — a price that was approximately 85% below the stock’s recent trading price following its 801% surge on Wednesday.

The sequence:

• Wednesday: YXT somehow surged +801% to approximately $48/ADS — a move driven by speculative momentum with no fundamental basis
• Thursday: The company announced a $1.05 million offering at $7.00/ADS — a price that implied management saw the $48 level as dramatically overvalued
• Thursday session: Stock collapsed -65% to $8.18 — a move from $48 to $8 in fewer than 24 hours represents the destruction of roughly 83% of peak market value in one session

The offering structure underscores the dysfunction: $1.05 million is an extraordinarily small offering — companies raise $1.05 million when they’re in capital distress, not when they’re creating strategic value. This wasn’t a growth raise; it was a survival raise priced at whatever the company could get.

For any trader who bought Wednesday’s momentum: The lesson is unambiguous. An 801% single-session move with no fundamental catalyst is a short seller’s setup, not an investment opportunity.

#2 — TDUP (ThredUp Inc.) | -47% to $3.36 — The Fast-Fashion Resale Platform Collapses on Guide Cut

Benzinga confirmed price: $3.36 (-47%) | Premarket: -30% to $4.40 before extending losses

ThredUp — the online resale platform for secondhand clothing — delivered a Q2 2026 earnings report that combined a Q2 EPS miss with a full-year 2026 revenue guidance cut below prior analyst estimates. The combination was lethal for the stock.

The Double Punch:

• Q2 EPS: Missed analyst consensus
• Q2 Revenue: Missed analyst consensus
• Full-Year 2026 Revenue Guidance: Cut below analyst estimates — the guidance reduction is typically more damaging than the current quarter miss because it resets the forward narrative

The structural headwind TDUP faces: Secondhand fashion platforms are battling a complicated macro environment — consumers are spending more cautiously (the “K-shaped” consumer weakness pattern flagged by multiple strategists this week), and while resale has structural growth tailwinds (sustainability, value-seeking), the company’s ability to monetize its inventory efficiently is the key variable. A guidance cut implies the monetization rate is running below expectations.

The pre-market to close extension: TDUP fell 30% in premarket, then dropped an additional 17% through the session to $3.36. This type of “extended fade” after an initial gap-down suggests institutional selling is not concentrated at the open — it’s sustained throughout the day, implying forced liquidation or large holder exits.

#3 — BIVI (BioVie Inc.) | -46.3% — Phase 2 Parkinson’s Data Faces Composite Endpoint Skepticism

Decline: -46.3% (StockMarketWatch confirmed) | Catalyst: Phase 2 Parkinson’s disease clinical trial data questioned by market

BioVie reported Phase 2 clinical data for its Parkinson’s disease program — and the market’s reaction was decisively negative, based specifically on methodological concerns about composite endpoint design.

The Scientific Concern:

A “composite endpoint” combines multiple outcome measures into a single trial measure. The concern is that if the individual components of a composite don’t each show significant improvement, the composite result can appear positive due to statistical aggregation — creating an illusion of efficacy that doesn’t reflect clinical reality.

In Parkinson’s disease specifically, the FDA has raised repeated concerns about composite endpoints in clinical trials for symptomatic improvement. Regulatory risk becomes the market’s primary concern when clinical data relies on composite outcomes that could be challenged in a future FDA New Drug Application.

The cascade: A -46.3% single-day drop signals that market participants believe BioVie’s Parkinson’s data is not FDA-approvable in its current form — which resets the entire valuation of the company’s lead program.

#4 — SNDK (SanDisk Corporation) | -13.1% on High Dollar Volume — The “Beat But Sell” Paradox

Decline: -13.1% (StockMarketWatch confirmed) | Volume: High dollar volume | YTD performance: Up ~469% before today

This is the day’s most intellectually interesting loser — because SanDisk actually delivered an exceptional Q4 2026 earnings report. Here’s the complete picture:

Q4 FY2026 Results (Reported August 5 After Close):

The Q1 Forward Guidance That Broke the Stock:

The Q4 beat was historic. The Q1 guidance miss was the only thing that mattered. Goldman Sachs analyst James Schneider had raised his SNDK price target to $2,200 from $1,200 on July 5 — expecting “a very strong quarter driven by continued NAND supply tightness.” The Q4 delivered exactly that. But the Q1 guide implies NAND pricing momentum is beginning to moderate.

The 469% YTD problem: When a stock has gained 469% in a year, there is virtually no margin for any downward guidance revision. A $650M Q1 revenue miss against estimates — even from an otherwise stellar Q4 — is sufficient to trigger the profit-taking that a 469% run has been building toward. The $14 billion buyback authorization is a meaningful signal of management’s long-term confidence; it didn’t matter today.

#5 — CLS (Celestica Inc.) | -15% Pre-Market — Secondary Offering Priced at 14.4% Discount

Celestica priced a 9.677 million share Spot Secondary at $310.00 — compared to the prior closing price of $362.76. That’s a 14.4% discount to market — and the market moved to price in the offering immediately.

Why secondaries are punished:

• A large block of shares priced at a discount signals either that the company needed capital urgently (bear case) or that existing shareholders (typically institutional holders of large locked-up positions) are exiting (also bearish near-term)
• The secondary adds new supply to the float precisely when the stock had been performing well
• Celestica’s -15% premarket move implies the full 14.4% discount plus additional selling beyond the offering price

Context: Celestica is an electronic manufacturing services company that has been benefiting from AI data center hardware assembly contracts. The secondary offering comes at a moment of peak valuation for the company — which is also why insiders chose this moment to access the capital market. That timing alignment with an elevated stock price is the most rational reason for a secondary — but it still creates near-term overhang.

#6 — MU (Micron Technology) | -5.6% — Memory Contagion Continues

Decline: -5.6% (StockMarketWatch confirmed)

Micron’s decline on August 6 is SanDisk’s guidance miss manifesting across the sector. When the memory sector leader guides below expectations — implying NAND pricing momentum is moderating — the contagion spreads to every memory-adjacent name.

The Micron paradox: Micron’s own Q3 2026 results (reported June 25) were extraordinary — EPS $25.11 vs $20.78 consensus, the biggest earnings beat of the quarter. Since then, the stock has experienced repeated pressure as the “peak cycle” narrative gains traction.

Semiconductor sector bifurcation: On a day where NVDA +1.1% and MSFT +1.8%, Micron and SanDisk are both negative. The market is clearly differentiating between AI chip designers (who benefit from demand acceleration) and AI chip manufacturers facing supply-demand normalization (who face margin normalization pressure).

#7 — SPCX (SpaceX) | Lockup Day — 911.5 Million Shares Hit the Market

Today is August 6, 2026 — SpaceX’s first post-IPO lockup expiration. Up to 911.5 million shares held by company insiders are now eligible for sale.

The Mechanics:

• First tranche: 20% of restricted holdings = 911.5 million shares
• Value at current prices (~$108-115 range): approximately $98-132 billion in eligible shares
• This represents roughly 68x the size of a typical large-cap lockup expiry
• The tradeable public float before today was approximately $86 billion — today’s unlock more than doubles that

The two-day setup:

• Tuesday (Q2 earnings day): SPCX initially rose 6% post-earnings, then fell below $125
• Wednesday: -11.26% to $111.22
• Thursday (lockup day): Continued pressure toward the 52-week low of $104.83

The constructive scenario (per IndMoney analysis): “A durable bottom becomes more plausible when a widely feared event occurs and the stock stops falling despite bad-looking headlines. The important test is not whether employees sell. It is whether the market can absorb their selling.”

The key insight on insider incentives: SpaceX option holders have a weighted-average exercise price of $27.65. At $111 per share, they still have ~$83/share in gross intrinsic value. RSU holders have an average grant date fair value of $54.84 — still profitable at $111. Both groups have substantial reason to sell into the market, even at discounted prices.

What to watch: If SPCX holds above the 52-week low of $104.83 through the first week of lockup selling, it may indicate that institutional demand is absorbing the supply. A break below $104.83 would be a new negative catalyst.

#8 — HUBS (HubSpot) and FIG (Figma) | Software Complex Under Pressure

Both HubSpot and Figma were called out in the Investrade morning preview as “weighing on the software complex” — with weaker-than-expected results contributing to broader software sector selling.

HubSpot (HUBS) context:

• HubSpot is a CRM and marketing automation platform serving small and mid-sized businesses
• Any weakness in SMB spending on SaaS tools is a red flag for the broader software sector
• With WPP (advertising) beating and SoundHound (AI applications) raising guidance, the divergence in software — HubSpot declining vs. these names rising — reflects a further segmentation: AI-native and AI-enabled application software is winning; legacy CRM/automation software is under pressure

Figma (FIG) context:

• Figma’s post-IPO trajectory has been challenging — RBC Capital cut its price target to $22 from $28 in July, citing uncertainty about AI monetization
• FIG was already trending toward record lows before Thursday; today’s software complex pressure extends that trend
• The competing dynamic: Adobe (Figma’s would-be acquirer, before the deal was blocked) is aggressively rolling out AI-powered design tools — reducing Figma’s competitive differentiation precisely at its most vulnerable post-IPO moment

#9 — The After-Close Earnings Slate That Will Define Friday

Tonight’s earnings calendar is the most consequential since bank earnings week in July:

The DraftKings risk: DKNG reports tonight with a backdrop of Flutter’s guidance slash earlier this week, Rush Street Interactive’s -13% post-earnings move, and Churchill Downs -6.6%. The consensus is pessimistic: Q2 EPS expected at $0.02 (down -42% YoY), revenue expected flat YoY, user base down 2.3% YoY. If DraftKings misses, the stock approaching its 52-week low of $20.46 is a real scenario.

The Airbnb opportunity: WPP’s advertising beat confirmed travel marketing is healthy. Delta Air Lines reported Q3 fuel cost tailwinds (oil down). If ABNB’s Q2 reflects strong World Cup travel demand and provides positive Q3 guidance, it could be the cleanest post-earnings winner of the evening.

#10 — The “Beat But Sell” Memory Paradox — What It Means for the Rest of Earnings Season

Thursday’s SanDisk and Western Digital experience — both beat Q4 estimates materially, both fell — reveals something crucial about August 2026 market dynamics:

The market is no longer rewarding current-quarter beats. It’s pricing Q1 and Q2 2027 trajectories.

For SNDK, the market looked past a $330M Q4 revenue beat and punished a $650M Q1 revenue guidance shortfall. The message to every CEO reporting in the next three weeks: the question is not “did you beat Q2” — it’s “what does Q3 look like, and can you raise the full year?”

This framework explains the entire August earnings divergence:

• SHOP +19.64%: Raised Q3 and full-year guidance above consensus
• APPS +32.60%: Raised FY27 revenue and EBITDA guidance above consensus
• SNDK -13.1%: Missed Q1 guidance despite beating Q4

The forward guide is the market. Everything else is context.

Follow TNN for daily stock market news and financial news today.

Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Always complete independent due diligence prior to executing equity trades.

_{^{Track today’s decliners at Yahoo Finance Losers | SanDisk investor relations at ir.sandisk.com | SpaceX lockup tracker at DayTradingToolkit SPCX}}

About The Author

Kasia Davis

See author's posts